Our Recommendations
- WHO consolidated guidelines on drug-resistant tuberculosis treatment (2019)
- Rapid Communication: Key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB) (2018)
- WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update (2016)
- Field Guide for the Management of Drug-Resistant Tuberculosis (2018)
- Вебинар: когорный анализ в рамках программного внедрения новых режимов лечения ЛУ-ТБ (2018)
New Publications
- Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, 2nd ed (2023)
- The use of next-generation sequencing for the surveillance of drug-resistant tuberculosis: an implementation manual (2023)
- Child-friendly formulations for drug-resistant tuberculosis (2022)
- WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment,update (2022)
- WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support (2022)
Filter
76
Featured
Recommendations
10
New Publications
15
Language
Document type
No document type
47
Guidelines
10
Manuals
6
Studies & Reports
6
Training Material
4
Online Courses
1
Videos
1
Fact sheets
1
Countries / Regions
Russia
4
Tajikistan
1
Colombia
1
Ukraine
1
El Salvador
1
Peru
1
Armenia
1
Global
1
Eastern Europe
1
India
1
Authors & Publishers
Publication Years
Category
TB
29
Policies & Guidelines HIV & TB
4
Disease Prevention & Control
2
Bacteriology
1
Public Health
1
Information, Education and Communication (IEC)
1
Studies & Reports
1
Capacity Building
1
Toolboxes
Of the more than 10 million people estimated to have fallen ill with tuberculosis (TB) in 2022, just over 400 000 people developed TB resistant to rifampicin (RIF), and 1.3 million people developed TB resistant isoniazid (INH). Drug resistance must be detected rapidly and accurately to initiate appr...
This document provides practical guidance on planning and implementing next-generation sequencing (NGS) technology for characterization of Mycobacterium tuberculosis complex (MTBC) bacteria. The aim is to detect mutations associated with drug resistance in the context of a surveillance system for tu...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on...
Technical information note. Ensuring an uninterrupted supply of quality-assured, affordable anti-TB
drugs and diagnostics to the world
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
Preventing tuberculosis infection from progressing to tuberculosis disease is a crucial component of the goal to eliminate tuberculosis. When deciding on the use of tuberculosis preventive therapy among household contacts, policy makers regularly ask questions, such as whether tuberculosis preventiv...
Se estima que unos 10 millones de personas contrajeron tuberculosis (TB) en el 2019 y que a unos 3 millones de ellas no se les diagnosticó ni se les notificó la enfermedad. Con el propósito de poner fin a la epidemia mundial de la tuberculosis para el 2030, sigue siendo necesario ampliar la capac...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
Las recomendaciones contenidas en este módulo son un componente de las directrices unificadas de la OMS sobre la tuberculosis (TB) y están destinadas principalmente para el uso de los programas nacionales de control de la tuberculosis, los organismos de salud pública y otros interesados clave que...
Pan American Journal of Public Health.
Objetivo. Identificar os fatores associados ao êxito do tratamento da tuberculose multirresistente (TBMR) relacionados ao paciente e à equipe de saúde nos seis municípios da Colômbia com o maior número de casos. Métodos. Mediante regresiones logísticas...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
This e-course will guide you through the essentials of latest existing WHO guidelines and policy recommendations on drug-resistant TB. You will also learn more about the rationale behind the WHO recommendations for the management of DR-TB, implementation considerations for different regimens for eli...
Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
Clinical guidelines for the comprehensive care of patients with drug-resistant tuberculosis
